文献速递药疹与重症皮肤不良反应

万古霉素相关药物性超敏综合征的临床表型

Vancomycin-associated drug-induced hypersensitivity syndrome.
PubMed 文献 · J Am Acad Dermatol · 2019-02-06

BACKGROUND: Although hypersensitivity reactions are well characterized for certain medications, vancomycin-associated drug-induced hypersensitivity syndrome (DIHS), or drug reaction with eosinophilia and systemic symptoms (DRESS), has yet to be defined.…

要点

  • 万古霉素相关DIHS/DRESS以肾功能受累负担更高为特征。
  • 文献中万古霉素诱导DIHS肾功能不全发生率达75%。
  • 回顾系列中万古霉素病例基线肌酐中位升高4.98倍。

核心结论

  • 万古霉素诱导的DIHS/DRESS呈现以肾功能受累负担更高为特征的独特表型。

研究设计与样本

  • 单中心学术机构8年回顾性病例系列,识别29例DIHS/DRESS中4例归因于万古霉素,并结合文献回顾补充28例万古霉素诱导DIHS及11例万古霉素相关急性间质性肾炎病例。

主要发现

  • 回顾系列中万古霉素诱导病例肾功能不全发生率为68%,文献回顾中为75%,均高于DIHS总体报道的10%-40%。

关键数值与推荐

  • 万古霉素诱导DIHS肾功能不全发生率:回顾系列68%,文献回顾75%。
  • DIHS总体肾功能不全报道发生率为10%-40%。

临床怎么用

  • 临床怀疑万古霉素相关DIHS/DRESS时应重点关注肾功能评估与监测。

局限性

  • 样本量小。
  • 研究为回顾性设计。
  • 缺乏确诊性肾活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although hypersensitivity reactions are well characterized for certain medications, vancomycin-associated drug-induced hypersensitivity syndrome (DIHS), or drug reaction with eosinophilia and systemic symptoms (DRESS), has yet to be defined. OBJECTIVE: To better define the clinical phenotype of vancomycin-associated DIHS. METHODS: A retrospective case series was conducted over an 8-year period at a single, academic institution. A total of 29 cases of DIHS/DRESS were identified, of which 4 were attributed to vancomycin. A literature review was performed; it identified 28 additional cases of vancomycin-induced DIHS. Vancomycin-associated acute interstitial nephritis was also reviewed to detect additional, previously uncharacterized cases of systemic hypersensitivity. The review yielded 11 additional cases. RESULTS: In this literature review and retrospective series, the incidence of renal dysfunction among vancomycin-induced cases (75% and 68% of cases in the series and literature, respectively) was notably higher than the overall reported incidence in DIHS (10%-40%). The degree of renal impairment was also significantly increased in the retrospective series (a median 4.98-fold change in baseline creatinine level vs a 2.25-fold increase in non-vancomycin-associated cases [P = .011]). LIMITATIONS: The principal limitation of this study is the small sample size. Other notable limitations include the retrospective nature of the study and absence of confirmatory renal biopsies. CONCLUSION: Although the current understanding of DIHS/DRESS is imperfect, our findings suggest that vancomycin-induced cases present with a unique phenotype characterized by a higher burden of renal involvement.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Madigan LM, Fox LP. Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol. 2019. PMID: 30738120. doi:10.1016/j.jaad.2019.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。